Effects of Reversion. With respect to each Prothena Reversion Antibody:
Effects of Reversion. With respect to each Co-Co Candidate and Co-Co Product that becomes a Jounce Reversion Product:
Effects of Reversion. With respect to each Co-Co Candidate and Co-Co Product that becomes a Jounce Reversion Product: CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.
Effects of Reversion. With respect to each Licensed Candidate and Licensed Product that becomes a Jounce Reversion Product:
Effects of Reversion. With respect to each Licensed Candidate, Licensed Product and Licensed Diagnostic Product that becomes a Juno Reversion Product:
Effects of Reversion. With respect to any Protein Therapeutic that becomes an OncoMed Reversion Compound:
Effects of Reversion. With respect to each Licensed Candidate and Licensed Product that becomes an OncoMed Reversion Product:
Effects of Reversion. With respect to each Co-Co Candidate and Co-Co Product that becomes an OncoMed Reversion Product:
Effects of Reversion. With respect to any [***] that becomes a Juno Reversion Compound:
Effects of Reversion. With respect to any [***] that becomes a Celgene Reversion Compound:
